# Molecular Diagnostics * **Definition:** A field of medicine that uses molecular biology techniques to diagnose diseases at the molecular level, often involving the analysis of specific sequences in DNA or RNA and biological markers in the genome and proteome. * **Taxonomy:** Healthcare Topics / Molecular Diagnostics ## News * Selected news on the topic of **Molecular Diagnostics**, for healthcare technology leaders * 6.3K news items are in the system for this topic * Posts have been filtered for tech and healthcare-related keywords | Date | Title | Source | | --- | --- | --- | | 5/15/2025 | [**In Vitro Diagnostics Market Share worth $150.13 billion, Globally by 2030 - PR Newswire**](https://www.prnewswire.com/news-releases/in-vitro-diagnostics-market-share-worth-150-13-billion-globally-by-2030---exclusive-report-by-the-research-insights-302456289.html) | [[PR Newswire]] | | 5/15/2025 | [**In Vitro Diagnostics Market Share worth $150.13 billion, Globally by 2030 - Yahoo Finance**](https://finance.yahoo.com/news/vitro-diagnostics-market-share-worth-140100190.html) | [[Yahoo Finance]] | | 5/14/2025 | [**South East Asia Molecular Diagnostics Market Forecast to 2031: PCR Technology Leads ...**](https://finance.yahoo.com/news/south-east-asia-molecular-diagnostics-083700498.html) | [[Yahoo Finance]] | | 5/1/2025 | [**Global Molecular Diagnostics Market to Expand at a CAGR of - Yahoo Finance**](https://finance.yahoo.com/news/global-molecular-diagnostics-market-expand-170000192.html) | [[Yahoo Finance]] | | 5/1/2025 | [**Global Molecular Diagnostics Market to Expand at a CAGR of ~9y 2032 Due to the Rising Demand for Precision Medicine - DelveInsight**](https://www.globenewswire.com/news-release/2025/05/01/3072699/0/en/Global-Molecular-Diagnostics-Market-to-Expand-at-a-CAGR-of-9-by-2032-Due-to-the-Rising-Demand-for-Precision-Medicine-DelveInsight.html) | [[Globe Newswire]] | | 4/29/2025 | [**Malaysia Molecular Diagnostics Market By Type - Key Market Players, Size 2033 - LinkedIn**](https://www.linkedin.com/pulse/malaysia-molecular-diagnostics-market-type-key-players-q2koe) | [[Linkedin]] | | 4/24/2025 | [**Molecular Diagnostics Market Set to Surge to USD 40.79 Billion by 2030, Driven by Technological Advancements and Rising Demand for Personalized Medicine**](http://prsync.com/maximize-market-research---mc/molecular-diagnostics-market-set-to-surge-to-usd--billion-by--driven-by-technological-advancements-and-rising-demand-for-persona-4726629/) | [[PRSync]] | | 4/22/2025 | [**Molecular Diagnostics Market Technologies, Products and Applications Report 2025: North ...**](https://finance.yahoo.com/news/molecular-diagnostics-market-technologies-products-082200844.html) | [[Yahoo Finance]] | | 3/27/2025 | [**Molecular Diagnostics Patent Landscape Report 2024: Key Trends, Technological ...**](https://finance.yahoo.com/news/molecular-diagnostics-patent-landscape-report-162000486.html) | [[Yahoo Finance]] | | 1/9/2025 | [**Transforming Healthcare: AI in Diagnostics Market to See 27.6AGR Growth**](https://finance.yahoo.com/news/transforming-healthcare-ai-diagnostics-market-183000797.html) | [[Yahoo Finance]] | | 1/6/2025 | [**Molecular Diagnostics Collaboration and Licensing Agreements Analysis Report 2024 with Directory of 747 Deals Signed Since 2016 by Company A-Z, Financial Terms, Deal Type and Therapy Area - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20250106275337/en/Molecular-Diagnostics-Collaboration-and-Licensing-Agreements-Analysis-Report-2024-with-Directory-of-747-Deals-Signed-Since-2016-by-Company-A-Z-Financial-Terms-Deal-Type-and-Therapy-Area---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 12/30/2024 | [**OTC/DTC Infectious Disease Diagnostics Strategies and Trends 2024-2029 with Market ...**](https://finance.yahoo.com/news/otc-dtc-infectious-disease-diagnostics-090100725.html) | [[Yahoo Finance]] | | 12/4/2024 | [**Molecular Diagnostics Market to grow by USD 7.92 Billion (2024-2028), driven by rising age ...**](https://www.prnewswire.com/news-releases/molecular-diagnostics-market-to-grow-by-usd-7-92-billion-2024-2028-driven-by-rising-age-related-diseases-report-highlights-ai-driven-transformation---technavio-302321169.html) | [[PR Newswire]] | | 11/13/2024 | [**AI in Clinical and Molecular Diagnostics Market Research Report 2024-2029 - Yahoo Finance**](https://finance.yahoo.com/news/ai-clinical-molecular-diagnostics-market-122100857.html) | [[Yahoo Finance]] | | 11/11/2024 | [**The Evolution of the COVID-19 Molecular Diagnostics Market: Key Shifts from 2024 to 2031**](https://www.linkedin.com/pulse/evolution-covid-19-molecular-diagnostics-market-key-shifts-eewxe) | [[Linkedin]] | | 11/1/2024 | [**Focusing on Molecular Diagnostics Systems Market Insight and Forecast Analysis (2024**](https://www.linkedin.com/pulse/molecular-diagnostics-systems-market-trends-focusing-insight-lgb7e) | [[Linkedin]] | | 10/15/2024 | [**Global Precancer Molecular Diagnostics Market Forecast (2024 - 2031): Trends, Impact Analysis ...**](https://www.linkedin.com/pulse/global-precancer-molecular-diagnostics-market-forecast-2024-lopwe) | [[Linkedin]] | | 10/6/2024 | [**COVID-19 Molecular Diagnostics Market Size, Share, Competitive Landscape and Trend ...**](https://www.linkedin.com/pulse/covid-19-molecular-diagnostics-market-size-share-competitive-iem0c) | [[Linkedin]] | | 10/4/2024 | [**UK Cervical Cancer Molecular Diagnostics Market Size by Application, by Types, by Region ...**](https://www.linkedin.com/pulse/uk-cervical-cancer-molecular-diagnostics-market-size-0ascf) | [[Linkedin]] | | 9/13/2024 | [**Molecular Diagnostics Market Innovations Investigated by In-Depth Analysis and ... - WhaTech**](https://www.whatech.com/og/markets-research/medical/880922-molecular-diagnostics-market-in-depth-analysis-and-marketing-strategies-by-2030.html) | whatech.com | | 9/12/2024 | [**Patient Engagement Challenges in Healthcare - MedTech Outlook**](https://www.medicaltechoutlook.com/news/patient-engagement-challenges-in-healthcare-nwid-3643.html) | medicaltechoutlook.com | | 9/11/2024 | [**Point of Care Molecular Diagnostics Market Trends and Strategy: $3.4 Billion Industry by ...**](https://www.whatech.com/og/markets-research/medical/878934-point-of-care-molecular-diagnostics-market-trends-and-strategy-3-4-billion-industry-by-2028.html) | whatech.com | | 9/2/2024 | [**Point-Of-Care Molecular Diagnostics Market Trends, Growth, Overview, Share Analysis, 2033**](https://www.whatech.com/og/markets-research/medical/874267-point-of-care-molecular-diagnostics-market-trends-growth-overview-share-analysis-2033.html) | whatech.com | | 7/11/2024 | [**Molecular Diagnostics Partnering Agreements Analysis Report and Directory 2016-2024: 740 Collaboration, Development, Research and Licensing Deals by Company A-Z, Deal Type and Therapy Area - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20240711457486/en/Molecular-Diagnostics-Partnering-Agreements-Analysis-Report-and-Directory-2016-2024-740-Collaboration-Development-Research-and-Licensing-Deals-by-Company-A-Z-Deal-Type-and-Therapy-Area---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 6/13/2024 | [**Flinn Foundation-Sponsored Study Identifies Three Bioscience Growth Areas to Advance Innovation and Economic Growth in Greater Phoenix**](http://www.businesswire.com/news/home/20240613324046/en/Flinn-Foundation-Sponsored-Study-Identifies-Three-Bioscience-Growth-Areas-to-Advance-Innovation-and-Economic-Growth-in-Greater-Phoenix/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | ## Topic Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **MGI Tech Co., Ltd.**: Developing cost-effective next-generation sequencing platforms for molecular diagnostics. - **Microbiologics**: Acquired SensID to enhance solutions in molecular diagnostics, particularly in oncology. - **Danaher Corporation**: Involved in developing advanced diagnostic technologies, including molecular diagnostics. - **Agilent Technologies**: A key contributor to the molecular diagnostics market, focusing on advanced diagnostic solutions. - **QIAGEN**: A leader in molecular diagnostics with a strong presence in the in vitro diagnostics market, focusing on expanding test offerings and strategic collaborations. - **BillionToOne**: A molecular diagnostics company specializing in prenatal and oncology testing, utilizing proprietary technology for precise DNA counting. - **Roche Diagnostics**: A leading company in molecular diagnostics, known for developing innovative diagnostic platforms and tests. - **Illumina**: A leader in next-generation sequencing technologies, significantly impacting molecular diagnostics. - **Abbott Laboratories**: A major player in molecular diagnostics, known for its innovative diagnostic technologies. - **BioMérieux**: A global leader in in vitro diagnostics, focusing on infectious disease diagnostics and molecular testing. - **Natera**: Specializes in genetic testing and non-invasive prenatal testing (NIPT), contributing to advancements in molecular diagnostics. - **Predica Diagnostics**: Known for its advanced cervical cancer screening tests, collaborating with MGI Tech. - **Hitachi High-Tech Corporation**: Engaged in developing cancer molecular diagnostics through strategic partnerships. - **Cepheid**: A molecular diagnostics company focused on developing and marketing user-friendly diagnostic systems for rapid and accurate testing solutions. - **Shanghai Biotecan Pharmaceuticals**: A leader in clinical molecular diagnostics in China, partnering with over 120 hospitals to provide precision medical services. - **CleanNA**: A manufacturer of nucleic acid extraction products, focusing on next-generation sequencing applications in clinical diagnostics. ### Partnerships and Collaborations - **CrisprBits and MolBio Diagnostics**: Collaborating to enhance testing capabilities in point-of-care molecular diagnostics. - **MGI Tech and Predica Diagnostics**: Collaborating to develop targeted RNA sequencing tests to enhance early cancer detection. - **AB ANALITICA and SNIBE**: Distribution partnership to develop next-generation molecular tests on the SNIBE Molecision R8 platform. - **Angsana Molecular & Diagnostics Laboratory and Pathnova Laboratories**: Merged to create Archerfish Precision Diagnostics, focusing on advanced diagnostic solutions. - **datma and GOAL**: Collaboration to enhance genomic testing and innovation among academic laboratories, promoting data-driven insights. - **OraSure Technologies and Sherlock Biosciences**: OraSure's acquisition of Sherlock enhances its diagnostic capabilities with advanced molecular diagnostics platforms. - **Thermo Fisher Scientific and Pfizer**: Collaborating to enhance next-generation sequencing testing capabilities globally. - **Seegene Inc., Microsoft, and Springer Nature**: Aiming to create a technology-sharing initiative for advanced diagnostics. - **BioAI and Genomic Testing Cooperative (GTC)**: Strategic collaboration to enhance biomarker discovery and diagnostics using AI. - **Hitachi High-Tech Corporation and Gencurix, Inc.**: Formed a strategic partnership to develop cancer molecular diagnostics testing services, focusing on biomarker discovery and digital technology. - **Genoks and Velsera**: Collaborating to enhance cancer diagnostics in Turkey by integrating advanced genomic analysis technologies. - **Gene Bio Medical and BIDIPHAR**: Joint venture to establish a diagnostic test kit production facility in Vietnam, leveraging Canadian technology. - **Genomics Plc and Vertex Pharmaceuticals**: Extended collaboration to discover and develop new precision medicines using genetic tools. - **JelloX Biotech Inc. and Mayo Clinic**: Collaboration to develop and validate 3D digital imaging and AI analysis technology for cancer diagnosis. - **BioNexus Gene Lab Corp. and Shenzhen Rongguang Health Group**: MOU to enhance cancer screening and precision medicine in Southeast Asia. - **Stilla and Avantor**: A distribution partnership aimed at enhancing access to digital PCR products in the US. - **Bumrungrad International Hospital and Golden Helix**: Multiyear agreement to integrate genomic technology into clinical workflows for precision medicine. ### Innovations, Trends, and Initiatives - **Advancements in Molecular Diagnostics**: The market is rapidly growing with developments in multiplex assays and nucleic acid testing, promising to transform diagnostics and treatment approaches. - **Point-of-Care Testing**: Growing trend in molecular diagnostics for quicker results and improved patient management. - **Artificial Intelligence Integration**: Enhancing efficiency and throughput in molecular diagnostics. - **Point-of-Care Molecular Diagnostics Growth**: Projected to grow from $2.0 billion in 2023 to $3.4 billion by 2028, driven by the need for rapid testing solutions. - **Emerging Technologies**: Utilization of PCR, next-generation sequencing, and microarrays for personalized medicine. - **Next-Generation Sequencing (NGS)**: Revolutionizing molecular diagnostics by enabling comprehensive genetic profiling for disease diagnosis and personalized medicine. - **Digital PCR Technology**: Stilla's Crystal Digital PCR technology shows exceptional performance in molecular diagnostics, particularly in AAV titration. - **Lab-on-a-Chip Technologies**: Adoption of compact diagnostic devices for decentralized testing. - **Real-time PCR Systems**: Projected market growth driven by advancements in molecular diagnostics and increasing applications in infectious disease detection and oncology. - **Liquid Biopsy Technologies**: Transforming cancer diagnostics and enabling personalized treatment strategies. - **CRISPR-based Diagnostics**: Developed by Dana-Farber Cancer Institute for rapid detection of gene fusions in leukemia, improving access to timely treatment. - **PCR Technology**: Dominating the molecular diagnostics market due to its application in COVID-19 testing, accounting for a significant market share. - **Precancer Molecular Diagnostics Market**: Projected growth driven by advancements in AI and genomic sequencing. - **Digital PCR**: Expected to grow rapidly due to increasing adoption for genetic disorder screening and infectious disease diagnostics. - **AI in Diagnostics**: The market for AI in clinical and molecular diagnostics is projected to grow significantly, driven by advancements in machine learning and personalized medicine. - **Smart Diagnostics**: Emerging focus on integrated diagnostics for comprehensive assessments. - **Automated Nucleic Acid Extraction Systems**: Growing demand for automation in laboratories to enhance efficiency and precision in diagnostics. ### Challenges and Concerns - **Regulatory Hurdles**: High development costs and stringent regulatory requirements pose challenges for molecular diagnostics. - **Regulatory Challenges**: The complexity, cost, and speed of regulatory processes can hinder the rapid development and deployment of molecular diagnostics. - **Regulatory Approval**: Challenges in obtaining regulatory approval for new molecular diagnostic products. - **Adoption Barriers**: Challenges in adopting molecular diagnostics over traditional imaging techniques, especially for neurodegenerative diseases. - **Skilled Workforce Shortage**: A shortage of skilled professionals in molecular diagnostics poses challenges for effective implementation and utilization. - **Market Conditions**: Fluctuations in market conditions affecting investment and growth in molecular diagnostics. - **Inadequate Medical Reimbursements**: A significant barrier to the expansion of the molecular diagnostics market. - **High Costs**: The high costs of advanced molecular diagnostic technologies can hinder adoption, especially in low-income areas. - **Inadequate Reimbursements**: Persisting challenges in the molecular diagnostics market, affecting the adoption of new technologies. - **Economic Trends**: Economic fluctuations may affect funding for diagnostic services and investments in molecular diagnostics. - **Market Saturation**: Potential saturation in the COVID-19 molecular diagnostics market due to evolving virus strains and reimbursement issues. - **Regulatory Uncertainties**: Concerns regarding the regulatory landscape affecting the adoption of new diagnostic technologies. - **High Costs of Advanced Diagnostics**: Challenges in women's health diagnostics include high costs and limited access to quality healthcare in low-income regions. - **Access to Technology**: Ensuring equitable access to advanced diagnostic technologies in various healthcare settings. - **High Implementation Costs**: Challenges in adopting precision medicine software due to costs and interoperability issues. - **FDA Regulations**: New regulations for in-house tests may increase costs and administrative burdens, potentially limiting the availability of lab-developed tests (LDTs). - **Regulatory Compliance**: Laboratories face pressure to meet stringent regulatory requirements, impacting operational efficiency. ## Related Topics [[Molecular Biomarkers]]; [[Molecular Biology]]; [[Molecular Genetic Pathology]]; [[Cancer Diagnostics]]; [[Medical Diagnostics]]; [[Clinical Diagnostics]]; [[Next Generation Cancer Diagnostics]]